BPG is committed to discovery and dissemination of knowledge
Home / Archive / Volume 24, Issue 27
This Article
Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
  • Total Article Views (23346)
All Articles published online
The chart showing PDF series, WORD series, HTML series, Figures (1-1) series.
Item 
Count 
PDF1519
WORD278
HTML18503
Figures (1-1)297
 Sum=20597
Publishing Process of This Article
The chart showing Browse series, Download series.
Item 
Count 
Browse1080
Download1669
 Sum=2749
Jul 21, 2018 (publication date) through Dec 1, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Cited by in CrossRef
For: Fang YL, Chen H, Wang CL, Liang L. Pathogenesis of non-alcoholic fatty liver disease in children and adolescence: From “two hit theory” to “multiple hit model”. World J Gastroenterol 2018; 24(27): 2974-2983 [PMID: 30038464 DOI: 10.3748/wjg.v24.i27.2974]
URL: https://www.wjgnet.com/1948-5182/full/v24/i27/2974.htm
Number Citing Articles
1
Liudmyla K. Parkhomenko, Larysa A. Strashok, Margaryta A. Khomenko. THE ROLE OF ZONULIN IN THE DEVELOPMENT OF LIVER FIBROSIS IN OBESE ADOLESCENTS. Wiadomości Lekarskie 2021; 74(1): 77 doi: 10.36740/WLek202101115
2
Chander K. Negi, Sabbir Khan, Hubert Dirven, Lola Bajard, Luděk Bláha. Flame Retardants-Mediated Interferon Signaling in the Pathogenesis of Nonalcoholic Fatty Liver Disease. International Journal of Molecular Sciences 2021; 22(8): 4282 doi: 10.3390/ijms22084282
3
Hai-Ling Peng, Li-Ni Liu, De-Liang Liu, Yu-Yong Tan. Depression and non-alcoholic fatty liver disease: Association and potential mechanisms. World Chinese Journal of Digestology 2022; 30(7): 295 doi: 10.11569/wcjd.v30.i7.295
Abstract() |  Core Tip() |  Full Article(HTML)() | Times Cited  (0) | Total Visits (0) | Open
4
Qiang Teng, Huihui Lv, Lingling Peng, Zhongyue Ren, Jiahui Chen, Lixue Ma, Hua Wei, Cuixiang Wan. Lactiplantibacillus plantarum ZDY2013 Inhibits the Development of Non-Alcoholic Fatty Liver Disease by Regulating the Intestinal Microbiota and Modulating the PI3K/Akt Pathway. Nutrients 2024; 16(7): 958 doi: 10.3390/nu16070958
5
Kavita Jadhav, Taylor S. Cohen. Can You Trust Your Gut? Implicating a Disrupted Intestinal Microbiome in the Progression of NAFLD/NASH. Frontiers in Endocrinology 2020; 11 doi: 10.3389/fendo.2020.592157
6
Xingxing Yuan, Liuxin Yang, Tinting Gao, Jiawei Gao, Bingyu Wang, Chengxiang Liu, Wei Yuan. YinChen WuLing powder attenuates non-alcoholic steatohepatitis through the inhibition of the SHP2/PI3K/NLRP3 pathway. Frontiers in Pharmacology 2024; 15 doi: 10.3389/fphar.2024.1423903
7
Laura G. Draijer, Denise Froon‐Torenstra, Michel van Weeghel, Frédéric M. Vaz, Anneloes E. Bohte, Adriaan G. Holleboom, Marc A. Benninga, Bart G.P. Koot. Lipidomics in Nonalcoholic Fatty Liver Disease. Journal of Pediatric Gastroenterology and Nutrition 2020; 71(4): 433 doi: 10.1097/MPG.0000000000002875
8
Simona Riccio, Rosa Melone, Caterina Vitulano, Pierfrancesco Guida, Ivan Maddaluno, Stefano Guarino, Pierluigi Marzuillo, Emanuele Miraglia del Giudice, Anna Di Sessa. Advances in pediatric non-alcoholic fatty liver disease: From genetics to lipidomics. World Journal of Clinical Pediatrics 2022; 11(3): 221-238 doi: 10.5409/wjcp.v11.i3.221
9
Zhaolin Sun, Yuhua Wei, Yuchen Xu, Jianwei Jiao, Xiuying Duan. The use of traditional Chinese medicine in the treatment of non-alcoholic fatty liver disease: A review. Pharmacological Research - Modern Chinese Medicine 2024; 12: 100475 doi: 10.1016/j.prmcm.2024.100475
10
Xianmin Dai, Jiayi Feng, Yi Chen, Si Huang, Xiaofei Shi, Xia Liu, Yang Sun. Traditional Chinese Medicine in nonalcoholic fatty liver disease: molecular insights and therapeutic perspectives. Chinese Medicine 2021; 16(1) doi: 10.1186/s13020-021-00469-4
11
Taís Menezes do Moinho, Sandro Leão Matos, Carla R. O. Carvalho. A comprehensive review on phytochemicals for fatty liver: are they potential adjuvants?. Journal of Molecular Medicine 2022; 100(3): 411 doi: 10.1007/s00109-021-02170-3
12
Mykhailo Buchynskyi, Valentyn Oksenych, Iryna Kamyshna, Sandor G. Vari, Aleksandr Kamyshnyi. Genetic Predictors of Comorbid Course of COVID-19 and MAFLD: A Comprehensive Analysis. Viruses 2023; 15(8): 1724 doi: 10.3390/v15081724
13
Claudia Theys, Tineke Vanderhaeghen, Evelien Van Dijck, Cedric Peleman, Anne Scheepers, Joe Ibrahim, Ligia Mateiu, Steven Timmermans, Tom Vanden Berghe, Sven M. Francque, Wim Van Hul, Claude Libert, Wim Vanden Berghe. Loss of PPARα function promotes epigenetic dysregulation of lipid homeostasis driving ferroptosis and pyroptosis lipotoxicity in metabolic dysfunction associated Steatotic liver disease (MASLD). Frontiers in Molecular Medicine 2024; 3 doi: 10.3389/fmmed.2023.1283170
14
Sean Backer, Deepesh Khanna. The Lasting Effects of COVID-19 on the Progression of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD). Cureus 2023;  doi: 10.7759/cureus.45231
15
Yana Sandlers, Rohan R. Shah, Ryan W. Pearce, Jaividhya Dasarathy, Arthur J. McCullough, Srinivasan Dasarathy. Plasma Krebs Cycle Intermediates in Nonalcoholic Fatty Liver Disease. Journal of Clinical Medicine 2020; 9(2): 314 doi: 10.3390/jcm9020314
16
Adiya E. Otumala, Dominick J. Hellen, C. Alessandra Luna, Priscilla Delgado, Anjana Dissanayaka, Chidozie Ugwumadu, Oluwamayokun Oshinowo, Md. Mydul Islam, Luyao Shen, Saul J. Karpen, David R. Myers. Opportunities and considerations for studying liver disease with microphysiological systems on a chip. Lab on a Chip 2023; 23(13): 2877 doi: 10.1039/D2LC00940D
17
Lijun Luo, Yongchun Chang, Li Sheng. Gut-liver axis in the progression of nonalcoholic fatty liver disease: From the microbial derivatives-centered perspective. Life Sciences 2023; 321: 121614 doi: 10.1016/j.lfs.2023.121614
18
V. I. Didenko, I. A. Klenina, О. M. Tatarchuk, O. I. Hrabovska, O. P. Petishko. Specificities of lipotoxicity of free fatty acids and cytokine profile in patients with chronic diffuse liver diseases . Regulatory Mechanisms in Biosystems 2021; 13(1): 3 doi: 10.15421/022201
19
Zhi Huang, Rong-Rong Zhou. Mechanism for FXR to regulate bile acid and glycolipid metabolism to improve NAFLD. World Chinese Journal of Digestology 2023; 31(19): 797 doi: 10.11569/wcjd.v31.i19.797
Abstract() |  Core Tip() |  Full Article(HTML)() | Times Cited  (0) | Total Visits (0) | Open
20
Qi Shao, Yiping Wu, Jing Ji, Tian Xu, Qiaoyu Yu, Chongyang Ma, Xuejing Liao, Fafeng Cheng, Xueqian Wang. Interaction Mechanisms Between Major Depressive Disorder and Non-alcoholic Fatty Liver Disease. Frontiers in Psychiatry 2021; 12 doi: 10.3389/fpsyt.2021.711835
21
Nana Wang, Yuan Huo, Xue Gao, Yuting Li, Fangru Cheng, Zengli Zhang. Lead exposure exacerbates liver injury in high-fat diet-fed mice by disrupting the gut microbiota and related metabolites. Food & Function 2024; 15(6): 3060 doi: 10.1039/D3FO05148J
22
Eda Kaya, Yusuf Yilmaz. Obesity and Diabetes. 2020; : 321 doi: 10.1007/978-3-030-53370-0_24
23
Liangying Ye, Dan Zhao, Yangzhi Xu, Jiaen Lin, Jiahui Xu, Kunyuan Wang, Zhanhui Ye, Yufeng Luo, Shiming Liu, Hui Yang. LncRNA-Gm9795 promotes inflammation in non-alcoholic steatohepatitis via NF-$$\kappa {}$$B/JNK pathway by endoplasmic reticulum stress. Journal of Translational Medicine 2021; 19(1) doi: 10.1186/s12967-021-02769-7
24
Jiayao Feng, Shuting Qiu, Shipeng Zhou, Yue Tan, Yan Bai, Hua Cao, Jiao Guo, Zhengquan Su. mTOR: A Potential New Target in Nonalcoholic Fatty Liver Disease. International Journal of Molecular Sciences 2022; 23(16): 9196 doi: 10.3390/ijms23169196
25
Xuecheng Li, Yi Lu, Xiaoshuang Liang, Xiaofei Zhou, Dirui Li, Zan Zhang, Yunchao Niu, Shuaishuai Liu, Ling Ye, Rufeng Zhang, Gianfranco D. Alpini. A new NASH model in aged mice with rapid progression of steatohepatitis and fibrosis. PLOS ONE 2023; 18(5): e0286257 doi: 10.1371/journal.pone.0286257
26
Kévin Bernal, Charbel Touma, Béatrice Le-Grand, Sophie Rose, Selenay Degerli, Valentine Genêt, Dominique Lagadic-Gossmann, Xavier Coumoul, Corinne Martin-Chouly, Sophie Langouët, Etienne B Blanc. Assessment of endocrine disruptor impacts on lipid metabolism in a fatty acid-supplemented HepaRG human hepatic cell line. Chemosphere 2024; 349: 140883 doi: 10.1016/j.chemosphere.2023.140883
27
Qian-Long Wu, Shu-Xin Zeng, Jia-Ying Peng, Yi Yuan, Zhi Zhu, Zi-Chun Xie, Ze-Hong Huang, Jia-Shuan Huang, Jian-Mei Lai, Jin-an Chen, Min-Hua Lin. Advances in metformin for the treatment of non-alcoholic fatty liver disease in children. Expert Review of Gastroenterology & Hepatology 2022; 16(9): 863 doi: 10.1080/17474124.2022.2118112
28
Ghazaleh Pourali, Zeinab S. Hosseini, Mina Maftooh, Elham Nazari, Majid Khazaei, Mohammadreza Nassiri, Seyed M. Hassanian, Majid Ghayour-Mobarhan, Gordon A. Ferns, Mohammad A. Kiani, Amir Avan. Therapeutic Potential of Herbal Medicine against Non-alcoholic Fatty Liver Disease. Current Drug Targets 2023; 24(4): 300 doi: 10.2174/1389450124666230113150116
29
Hae-Jin Ko, Sarah Woo, Junhee Han, Yoon Myung Kim, Hyun Jung Lim, Min-Jeong Kim, Yong Soon Park, Kyung Hee Park. Which obesity index is the most useful marker for predicting hepatic steatosis in children and adolescents with obesity? A cross-sectional study using quantitative magnetic resonance imaging. Obesity Research & Clinical Practice 2023; 17(4): 335 doi: 10.1016/j.orcp.2023.05.013
30
Mingzhe Zhu, Meng Li, Wenjun Zhou, Yang Yang, Fenghua Li, Li Zhang, Guang Ji. Qianggan extract improved nonalcoholic steatohepatitis by modulating lncRNA/circRNA immune ceRNA networks. BMC Complementary and Alternative Medicine 2019; 19(1) doi: 10.1186/s12906-019-2577-6
31
Zhibin Yan, Xiaokang Miao, Bangzhi Zhang, Junqiu Xie. p53 as a double-edged sword in the progression of non-alcoholic fatty liver disease. Life Sciences 2018; 215: 64 doi: 10.1016/j.lfs.2018.10.051
32
Yiyuan Zheng, Dan Fang, Chaoyuan Huang, Lina Zhao, Liming Gan, Youlan Chen, Fengbin Liu. Gentiana scabra Restrains Hepatic Pro-Inflammatory Macrophages to Ameliorate Non-Alcoholic Fatty Liver Disease. Frontiers in Pharmacology 2022; 12 doi: 10.3389/fphar.2021.816032
33
Ruwen Yang, Jingyu Shang, Yaru Zhou, Weiwei Liu, Yaozhou Tian, Hongtao Shang. Effects of probiotics on nonalcoholic fatty liver disease: a systematic review and meta-analysis. Expert Review of Gastroenterology & Hepatology 2021; 15(12): 1401 doi: 10.1080/17474124.2022.2016391
34
Eliut Pérez Sánchez, Adriana Corona-Pérez, Omar Arroyo-Helguera, Ida Soto Rodríguez, Senobia Rosalía Cruz Lumbreras, Jorge Rodríguez-Antolín, Estela Cuevas Romero, Leticia Nicolás-Toledo. Chronic unpredictable mild stress increases serum aldosterone without affecting corticosterone levels and induces hepatic steatosis and renal injury in young adult male rats. Journal of Molecular Histology 2024; 55(3): 265 doi: 10.1007/s10735-024-10188-3
35
Mengting Chen, Pengfei Hou, Min Zhou, Qingbo Ren, Xiaolan Wang, Li Huang, Suocheng Hui, Long Yi, Mantian Mi. Resveratrol attenuates high-fat diet-induced non-alcoholic steatohepatitis by maintaining gut barrier integrity and inhibiting gut inflammation through regulation of the endocannabinoid system. Clinical Nutrition 2020; 39(4): 1264 doi: 10.1016/j.clnu.2019.05.020
36
Jerad H. Dumolt, Min Ma, Joyce Mathew, Mulchand S. Patel, Todd C. Rideout. Gestational hypercholesterolemia alters fetal hepatic lipid metabolism and microRNA expression in Apo-E-deficient mice. American Journal of Physiology-Endocrinology and Metabolism 2019; 317(5): E831 doi: 10.1152/ajpendo.00138.2019
37
Zhuo-yuan Wang, Si-ting Gao, Xiao-jun Gou, Fu-rong Qiu, Qin Feng. IL-1 receptor-associated kinase family proteins: An overview of their role in liver disease. European Journal of Pharmacology 2024; 978: 176773 doi: 10.1016/j.ejphar.2024.176773
38
Y Saigo, T Sasase, M Tohma, K Uno, Y Shinozaki, T Maekawa, R Sano, K Miyajima, T Ohta. High-Cholesterol Diet in Combination With Hydroxypropyl-β Cyclodextrin Induces NASH-Like Disorders in the Liver of Rats. Physiological Research 2023; 72(3) doi: 10.33549/physiolres.934981
39
Melisa Kozaczek, Walter Bottje, Byungwhi Kong, Diyana Albataineh, Reza Hakkak. A Comparison of Short- and Long-Term Soy Protein Isolate Intake and Its Ability to Reduce Liver Steatosis in Obese Zucker Rats Through Modifications of Genes Involved in Inflammation and Lipid Transport. Journal of Medicinal Food 2021; 24(9): 1010 doi: 10.1089/jmf.2020.0180
40
Rubén Peña-Vélez, Nayely Garibay-Nieto, Manuel Cal-y-Mayor-Villalobos, Estibalitz Laresgoiti-Servitje, Karen Pedraza-Escudero, María del Carmen García-Blanco, Omar Alfonso Heredia-Nieto, Eréndira Villanueva-Ortega. Association between neck circumference and non-alcoholic fatty liver disease in Mexican children and adolescents with obesity. Journal of Pediatric Endocrinology and Metabolism 2020; 33(2): 205 doi: 10.1515/jpem-2019-0204
41
Mario Bartiromo, Michele Nardolillo, Serena Ferrara, Giuseppina Russo, Emanuele Miraglia Del Giudice, Anna Di Sessa. The challenging role of micro-RNAs in non-alcoholic fatty liver disease in children with obesity: is it time for a new era?. Expert Review of Gastroenterology & Hepatology 2023; 17(8): 817 doi: 10.1080/17474124.2023.2242245
42
Xiao-Qian Shan, Lan Zhao. Enhancing the functionality of mesenchymal stem cells: An attractive treatment strategy for metabolic dysfunction-associated steatotic liver disease?. World Journal of Stem Cells 2024; 16(10): 854-859 doi: 10.4252/wjsc.v16.i10.854
43
Jeanette Irene Christiene Manoppo, Vivekenanda Pateda, Cindy Prayogo, Fima L. F. G. Langi, Fahrul Nurkolis, Apollinaire Tsopmo. Relationships of 25-hydroxyvitamin D levels and non-alcoholic fatty liver disease in obese children: A possible strategy to promote early screening of NAFLD. Frontiers in Nutrition 2022; 9 doi: 10.3389/fnut.2022.1025396
44
Sana Raza, Sangam Rajak, Rajani Singh, Jin Zhou, Rohit A Sinha, Amit Goel. Cell-type specific role of autophagy in the liver and its implications in non-alcoholic fatty liver disease. World Journal of Hepatology 2023; 15(12): 1272-1283 doi: 10.4254/wjh.v15.i12.1272
45
Yong Tae Park, Eui Yup Chung, Chang Ho Chae, Young Hoon Lee. Association between serum perfluoroalkyl substances concentrations and non-alcoholic fatty liver disease among Korean adults: a cross-sectional study using the National Environmental Health Survey cycle 4. Annals of Occupational and Environmental Medicine 2024; 36(1) doi: 10.35371/aoem.2024.36.e10
46
Timothy P. LaBranche, Anna K. Kopec, Srinivasa R. Mantena, Brett D. Hollingshead, Andrew W. Harrington, Zachary S. Stewart, Yutian Zhan, Kyle D. Hayes, Laurence O. Whiteley, Andrew D. Burdick, John W. Davis. Zucker Lean Rats With Hepatic Steatosis Recapitulate Asymptomatic Metabolic Syndrome and Exhibit Greater Sensitivity to Drug-Induced Liver Injury Compared With Standard Nonclinical Sprague-Dawley Rat Model. Toxicologic Pathology 2020; 48(8): 994 doi: 10.1177/0192623320968716
47
Mariana M. Ramírez-Mejía, Xingshun Qi, Ludovico Abenavoli, Manuel Romero-Gómez, Mohammed Eslam, Nahum Méndez-Sánchez. Metabolic dysfunction: The silenced connection with fatty liver disease. Annals of Hepatology 2023; 28(6): 101138 doi: 10.1016/j.aohep.2023.101138
48
Hongying Yang, Dongyun Wei, Yao Zhang, Wenxuan Jian. Huangqin-Huanglian Decoction Protects Liver against Non-alcoholic Fatty Liver Disease in High Fat-diet Mice. Endocrine, Metabolic & Immune Disorders - Drug Targets 2024; 24(6): 691 doi: 10.2174/0118715303257018230927182802
49
Shiqi Hao, Liang Ming, Yafei Li, Haodi Lv, Lin Li, Tuyatsetseg Jambal, Rimutu Ji. Modulatory effect of camel milk on intestinal microbiota of mice with non-alcoholic fatty liver disease. Frontiers in Nutrition 2022; 9 doi: 10.3389/fnut.2022.1072133
50
Marta Flisiak-Jackiewicz, Anna Bobrus-Chociej, Natalia Wasilewska, Dariusz Marek Lebensztejn. From Nonalcoholic Fatty Liver Disease (NAFLD) to Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD)—New Terminology in Pediatric Patients as a Step in Good Scientific Direction?. Journal of Clinical Medicine 2021; 10(5): 924 doi: 10.3390/jcm10050924
51
Keishi Kisoh, Go Sugahara, Yuko Ogawa, Suzue Furukawa, Yuji Ishida, Takeshi Okanoue, Michinori Kohara, Chise Tateno. Estimating Drug Efficacy with a Diet-Induced NASH Model in Chimeric Mice with Humanized Livers. Biomedicines 2021; 9(11): 1647 doi: 10.3390/biomedicines9111647
52
V. T. Ivashkin, M. V. Maevskaya, M. S. Zharkova, Yu. V. Kotovskaya, O. N. Tkacheva, E. A. Troshina, M. V. Shestakova, I. V. Maev, V. V. Breder, N. I. Gheivandova, V. L. Doshchitsin, E. N. Dudinskaya, E. V. Ershova, Kh. B. Kodzoeva, K. A. Komshilova, N. V. Korochanskaya, A. Yu. Mayorov, E. E. Mishina, M. Yu. Nadinskaya, I. G. Nikitin, N. V. Pogosova, A. I. Tarzimanova, M. Sh. Shamkhalova. Clinical Practice Guidelines of the Russian Scientific Liver Society, Russian Gastroenterological Association, Russian Association of Endocrinologists, Russian Association of Gerontologists and Geriatricians and National Society for Preventive Cardiology on Diagnosis and Treatment of Non-Alcoholic Liver Disease. Russian Journal of Gastroenterology, Hepatology, Coloproctology 2022; 32(4): 104 doi: 10.22416/1382-4376-2022-32-4-104-140
53
Jing-Jie Wang, Yi-Tong Zhang, Yu Jen Tseng, Jun Zhang. miR-222 targets ACOX1, promotes triglyceride accumulation in hepatocytes. Hepatobiliary & Pancreatic Diseases International 2019; 18(4): 360 doi: 10.1016/j.hbpd.2019.05.002
54
Xushan Yang, Yudi Deng, Yali Tu, Dongliang Feng, Wenzhen Liao. Nobiletin mitigates NAFLD via lipophagy and inflammation. Food & Function 2022; 13(19): 10186 doi: 10.1039/D2FO01682F
55
Antonella Mosca, Luca Della Volpe, Maria Rita Sartorelli, Donatella Comparcola, Silvio Veraldi, Anna Alisi, Giuseppe Maggiore. Metabolic Associated Fatty Liver Disease in Children and Adolescents: Mechanisms of a Silent Epidemic and Therapeutic Options. Current Pediatric Reviews 2024; 20(3): 296 doi: 10.2174/1573396319666230403121805
56
Fangfang Chen, Hanna Friederike Willenbockel, Thekla Cordes. Mapping the Metabolic Niche of Citrate Metabolism and SLC13A5. Metabolites 2023; 13(3): 331 doi: 10.3390/metabo13030331
57
Gary Huang, Daniel F. Wallace, Elizabeth E. Powell, Tony Rahman, Paul J. Clark, V. Nathan Subramaniam. Gene Variants Implicated in Steatotic Liver Disease: Opportunities for Diagnostics and Therapeutics. Biomedicines 2023; 11(10): 2809 doi: 10.3390/biomedicines11102809
58
Zhe-Wen Qin, Qian-Nan Ren, Hong-Xi Zhang, Ya-Ru Liu, Ke Huang, Wei Wu, Guan-Ping Dong, Yan Ni, Jun-Fen Fu. Development and validation of a novel non-invasive test for diagnosing nonalcoholic fatty liver disease in Chinese children. World Journal of Pediatrics 2024; 20(4): 413 doi: 10.1007/s12519-023-00704-y
59
Paola Mogna-Peláez, Ana Romo-Hualde, José I. Riezu-Boj, Fermin I. Milagro, David Muñoz-Prieto, José I. Herrero, Mariana Elorz, Alberto Benito-Boillos, J. Ignacio Monreal, Josep A. Tur, Alfredo Martínez, Itziar Abete, M. Angeles Zulet. Isoliquiritigenin in combination with visceral adipose tissue and related markers as a predictive tool for nonalcoholic fatty liver disease. Journal of Physiology and Biochemistry 2024; 80(3): 639 doi: 10.1007/s13105-023-00998-6
60
Runbin Sun, Dan Xu, Qingli Wei, Bangling Zhang, Jiye Aa, Guangji Wang, Yuan Xie. Silybin ameliorates hepatic lipid accumulation and modulates global metabolism in an NAFLD mouse model. Biomedicine & Pharmacotherapy 2020; 123: 109721 doi: 10.1016/j.biopha.2019.109721
61
Magdalena A. Maj, Douglas G. Burrin, Rodrigo Manjarín. Decreased FXR Agonism in the Bile Acid Pool Is Associated with Impaired FXR Signaling in a Pig Model of Pediatric NAFLD. Biomedicines 2023; 11(12): 3303 doi: 10.3390/biomedicines11123303
62
Yuqiao Liu, Yue Fan, Jibin Liu, Xiyang Liu, Xiuyan Li, Jingqing Hu. Application and mechanism of Chinese herb medicine in the treatment of non-alcoholic fatty liver disease. Frontiers in Pharmacology 2024; 15 doi: 10.3389/fphar.2024.1499602
63
Nannan Sun, Chuangpeng Shen, Lei Zhang, Xiaojie Wu, Yuanyuan Yu, Xiaoying Yang, Chen Yang, Chong Zhong, Zhao Gao, Wei Miao, Zehong Yang, Weihang Gao, Ling Hu, Kevin Williams, Changhui Liu, Yongsheng Chang, Yong Gao. Hepatic Krüppel-like factor 16 (KLF16) targets PPARα to improve steatohepatitis and insulin resistance. Gut 2021; 70(11): 2183 doi: 10.1136/gutjnl-2020-321774
64
J. Carretero-Gómez, F.J. Carrasco-Sánchez, J.M. Fernández-Rodríguez, P. Casado-Escribano, J.P. Miramontes-González, J.M. Seguí-Ripoll, J. Ena, J.C. Arévalo-Lorido. Efecto de semaglutida sobre los biomarcadores de la enfermedad del hígado graso en pacientes con diabetes y obesidad. Revista Clínica Española 2023; 223(3): 134 doi: 10.1016/j.rce.2022.11.007
65
Mohammad Habibullah, Khaleed Jemmieh, Amr Ouda, Mohammad Zulqurnain Haider, Mohammed Imad Malki, Abdel-Naser Elzouki. Metabolic-associated fatty liver disease: a selective review of pathogenesis, diagnostic approaches, and therapeutic strategies. Frontiers in Medicine 2024; 11 doi: 10.3389/fmed.2024.1291501
66
Aurelio Seidita, Alessandra Cusimano, Alessandra Giuliano, Maria Meli, Antonio Carroccio, Maurizio Soresi, Lydia Giannitrapani. Oxidative Stress as a Target for Non-Pharmacological Intervention in MAFLD: Could There Be a Role for EVOO?. Antioxidants 2024; 13(6): 731 doi: 10.3390/antiox13060731
67
M. Gaschinard, C. Tetard, D. Lamireau, J.-F. Chateil, B. Le Bail, H. Thibault, D. Guimber, T. Lamireau, R. Enaud. Découverte d’une stéatose hépatique chez l’enfant. Perfectionnement en Pédiatrie 2021; 4(1): 44 doi: 10.1016/j.perped.2021.01.004
68
Zhi-Sen Pan, Yan-Ling Chen, Kai-Jia Tang, Zhang-Zhou Liu, Jia-Li Liang, Yan-Hao Guan, Xiao-Yi Xin, Chang-Hui Liu, Chuang-Peng Shen. Pachymic acid modulates sirtuin 6 activity to alleviate lipid metabolism disorders. Experimental and Therapeutic Medicine 2023; 26(1) doi: 10.3892/etm.2023.12019
69
Giovanni Catalano, Odysseas P. Chatzipanagiotou, Jun Kawashima, Timothy M. Pawlik. Metabolic-associated steatotic liver disease and hepatocellular carcinoma. Expert Opinion on Pharmacotherapy 2024; 25(17): 2283 doi: 10.1080/14656566.2024.2426680
70
Xing Yan, Linnan Li, Pei Liu, Jie Xu, Zhengtao Wang, Lili Ding, Li Yang. Targeted metabolomics profiles serum fatty acids by HFD induced non-alcoholic fatty liver in mice based on GC-MS. Journal of Pharmaceutical and Biomedical Analysis 2022; 211: 114620 doi: 10.1016/j.jpba.2022.114620
71
Karthik Shree Harini, Devaraj Ezhilarasan. Wnt/beta‐catenin signaling and its modulators in nonalcoholic fatty liver diseases. Hepatobiliary & Pancreatic Diseases International 2023; 22(4): 333 doi: 10.1016/j.hbpd.2022.10.003
72
Md. Arifur Rahman Chowdhury, Jungeun An, Sangyun Jeong. The Pleiotropic Face of CREB Family Transcription Factors. Molecules and Cells 2023; 46(7): 399 doi: 10.14348/molcells.2023.2193
73
Qin Guo, Yun Li, Xin Dai, Bangmao Wang, Jie Zhang, Hailong Cao. Polysaccharides: The Potential Prebiotics for Metabolic Associated Fatty Liver Disease (MAFLD). Nutrients 2023; 15(17): 3722 doi: 10.3390/nu15173722
74
Ebe D'Adamo, Valeria Castorani, Valerio Nobili. The Liver in Children With Metabolic Syndrome. Frontiers in Endocrinology 2019; 10 doi: 10.3389/fendo.2019.00514
75
Joon Beom Park, Kangeun Ko, Yang Hyun Baek, Woo Young Kwon, Sunghwan Suh, Song-Hee Han, Yun Hak Kim, Hye Young Kim, Young Hyun Yoo. Pharmacological Prevention of Ectopic Erythrophagocytosis by Cilostazol Mitigates Ferroptosis in NASH. International Journal of Molecular Sciences 2023; 24(16): 12862 doi: 10.3390/ijms241612862
76
Jie‐Lei Zhang, Bin‐Bin Du, Dian‐Hong Zhang, Huan Li, Ling‐Yao Kong, Guang‐Jian Fan, Ya‐Peng Li, Peng‐Cheng Li, Cui Liang, Zheng Wang, Lu‐Lu Yang, Zheng‐Yang Hao, Lei‐Ming Wu, Zhen Huang, Jian‐Zeng Dong, Jin‐Ying Zhang, Rui Yao, Shou‐Jun Wang, Yan‐Zhou Zhang. OTUB1 alleviates NASH through inhibition of the TRAF6‐ASK1 signaling pathways. Hepatology 2022; 75(5): 1218 doi: 10.1002/hep.32179
77
Resthie R. Putri, Thomas Casswall, Emilia Hagman. Risk and protective factors of non‐alcoholic fatty liver disease in paediatric obesity: A nationwide nested case–control study. Clinical Obesity 2022; 12(2) doi: 10.1111/cob.12502
78
Weisong Cai, Sa Wu, Xiaoping Ming, Zhen Li, Dingyu Pan, Xiuping Yang, Minlan Yang, Yufeng Yuan, Xiong Chen. IL6 Derived from Macrophages under Intermittent Hypoxia Exacerbates NAFLD by Promoting Ferroptosis via MARCH3‐Led Ubiquitylation of GPX4. Advanced Science 2024; 11(41) doi: 10.1002/advs.202402241
79
Yingyi Huang, Xiang Liu, Hong-Yan Wang, Jian-Yang Chen, Xianghui Zhang, Yubang Li, Yifang Lu, Zhongdian Dong, Kaiqiang Liu, Zhongduo Wang, Qian Wang, Guangyi Fan, Jun Zou, Shanshan Liu, Changwei Shao. Single-cell transcriptome landscape of zebrafish liver reveals hepatocytes and immune cell interactions in understanding nonalcoholic fatty liver disease. Fish & Shellfish Immunology 2024; 146: 109428 doi: 10.1016/j.fsi.2024.109428
80
Moumita Saha, Krishnendu Manna, Krishna Das Saha. Melatonin Suppresses NLRP3 Inflammasome Activation via TLR4/NF-κB and P2X7R Signaling in High-Fat Diet-Induced Murine NASH Model. Journal of Inflammation Research 2022; : 3235 doi: 10.2147/JIR.S343236
81
ChenLu Zhao, JunHao Shi, DongFang Shang, Min Guo, Cheng Zhou, WenXia Zhao. Protective effect of phytoestrogens on nonalcoholic fatty liver disease in postmenopausal women. Frontiers in Pharmacology 2023; 14 doi: 10.3389/fphar.2023.1237845
82
Li-ping Zhang, Hua-xing Wei, Shi-hui Lin, Bin-wei Qiu, Jin-liang Lin. Cotinine exposure enhances the association of blood manganese and non-alcoholic fatty liver disease in American children: a cross-sectional study. Scientific Reports 2024; 14(1) doi: 10.1038/s41598-024-75298-0
83
Arnab Banerjee, Debasmita Das, Rajarshi Paul, Sandipan Roy, Ujjal Das, Samrat Saha, Sanjit Dey, Arghya Adhikary, Sandip Mukherjee, Bithin Kumar Maji. Mechanistic study of attenuation of monosodium glutamate mixed high lipid diet induced systemic damage in rats by Coccinia grandis. Scientific Reports 2020; 10(1) doi: 10.1038/s41598-020-72076-6
84
Zoran Gluvic, Ratko Tomasevic, Ksenija Bojovic, Milan Obradovic, Esma R. Isenovic. Non-alcoholic fatty liver disease: a multidisciplinary clinical practice approach—the institutional adaptation to existing Clinical Practice Guidelines. Emergency and Critical Care Medicine 2022; 2(1): 12 doi: 10.1097/EC9.0000000000000016
85
Xiaomin Luo, Boyu Zhang, Yehua Pan, Jian Gu, Rui Tan, Puyang Gong. Phyllanthus emblica aqueous extract retards hepatic steatosis and fibrosis in NAFLD mice in association with the reshaping of intestinal microecology. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.893561
86
Reham Mohammed Dawood, Ghada Maher Salum, Mai Abd El-Meguid, Basma EL-sayed Fotouh. Molecular Insights of Nonalcoholic Fatty Liver Disease Pathogenesis. Journal of Interferon & Cytokine Research 2024; 44(3): 111 doi: 10.1089/jir.2023.0162
87
Carolina Gabriela Plazas Guerrero, Selene De Jesús Acosta Cota, Francisco Humberto Castro Sánchez, Marcela De Jesús Vergara Jiménez, Efrén Rafael Ríos Burgueño, Juan Ignacio Sarmiento Sánchez, Lorenzo Antonio Picos Corrales, Ulises Osuna Martínez. Evaluation of sucrose-enriched diet consumption in the development of risk factors associated to type 2 diabetes, atherosclerosis and non-alcoholic fatty liver disease in a murine model. International Journal of Environmental Health Research 2021; 31(6): 651 doi: 10.1080/09603123.2019.1680817
88
Amirhossein Tamimi, Mona Javid, Nasrin Sedighi-Pirsaraei, Arian Mirdamadi. Exosome prospects in the diagnosis and treatment of non-alcoholic fatty liver disease. Frontiers in Medicine 2024; 11 doi: 10.3389/fmed.2024.1420281
89
Evelyn Nunes Goulart da Silva Pereira, Daniela Polessa Paula, Beatriz Peres de Araujo, Maria de Jesus Mendes da Fonseca, Maria de Fátima Haueisen Sander Diniz, Anissa Daliry, Rosane Harter Griep. Advanced glycation end product: A potential biomarker for risk stratification of non-alcoholic fatty liver disease in ELSA-Brasil study. World Journal of Gastroenterology 2021; 27(29): 4913-4928 doi: 10.3748/wjg.v27.i29.4913
90
Priyankar Dey, Richard S. Bruno. Dietary Supplements with Antioxidant Activity. 2023; : 80 doi: 10.1039/BK9781839166112-00080
91
Sina Kalantari Soltanieh, Sahar Khastar, Irwanjot Kaur, Abhishek Kumar, Jaya Bansal, Ata Fateh, Deepak Nathiya, Beneen Husseen, Mansour Rajabivahid, Mahmoud Dehghani-Ghorbi, Reza Akhavan-Sigari. Long Non-Coding RNAs in Non-Alcoholic Fatty Liver Disease; Friends or Foes?. Cell Biochemistry and Biophysics 2024;  doi: 10.1007/s12013-024-01555-8
92
Athanasios N. Tsartsalis, Anna Tagka, Athanasios Kotoulas, Daphne Mirkopoulou, Styliani A. Geronikolou, Lambrou G. GeNeDis 2020. Advances in Experimental Medicine and Biology 2021; 1338: 117 doi: 10.1007/978-3-030-78775-2_14
93
Songsong Wang, Feiya Sheng, Liang Zou, Jianbo Xiao, Peng Li. Hyperoside attenuates non-alcoholic fatty liver disease in rats via cholesterol metabolism and bile acid metabolism. Journal of Advanced Research 2021; 34: 109 doi: 10.1016/j.jare.2021.06.001
94
J.B. Armengaud, C. Yzydorczyk, B. Siddeek, A.C. Peyter, U. Simeoni. Intrauterine growth restriction: Clinical consequences on health and disease at adulthood. Reproductive Toxicology 2021; 99: 168 doi: 10.1016/j.reprotox.2020.10.005
95
Abdul Moeed, Muhammad Omar Larik, Muhammad Ahmed Ali Fahim, Hafsah Alim Ur Rahman, Lubna Najmi, Mah I Kan Changez, Muhammad Moiz Javed, Md Al Hasibuzzaman. Impact of non-alcoholic fatty liver disease on coronavirus disease 2019: A systematic review. World Journal of Hepatology 2024; 16(8): 1185-1198 doi: 10.4254/wjh.v16.i8.1185
96
Katarzyna Marcinkiewicz, Anita Horodnicka-Józwa, Tomasz Jackowski, Kamila Strączek, Agnieszka Biczysko-Mokosa, Mieczysław Walczak, Elżbieta Petriczko. Nonalcoholic fatty liver disease in children with obesity– observations from one clinical centre in the Western Pomerania region. Frontiers in Endocrinology 2022; 13 doi: 10.3389/fendo.2022.992264
97
Pin-Nan Cheng, Wen-Jone Chen, Charles Jia-Yin Hou, Chih-Lin Lin, Ming-Ling Chang, Chia-Chi Wang, Wei-Ting Chang, Chao-Yung Wang, Chun-Yen Lin, Chung-Lieh Hung, Cheng-Yuan Peng, Ming-Lung Yu, Ting-Hsing Chao, Jee-Fu Huang, Yi-Hsiang Huang, Chi-Yi Chen, Chern-En Chiang, Han-Chieh Lin, Yi-Heng Li, Tsung-Hsien Lin, Jia-Horng Kao, Tzung-Dau Wang, Ping-Yen Liu, Yen-Wen Wu, Chun-Jen Liu. Taiwan Association for the Study of the Liver-Taiwan Society of Cardiology Taiwan position statement for the management of metabolic dysfunction- associated fatty liver disease and cardiovascular diseases. Clinical and Molecular Hepatology 2023; 30(1): 16 doi: 10.3350/cmh.2023.0315
98
Wenji Zhang, Hui Lin, Wenli Cheng, Zhenrui Huang, Wenjuan Zhang. Protective Effect and Mechanism of Plant-Based Monoterpenoids in Non-alcoholic Fatty Liver Diseases. Journal of Agricultural and Food Chemistry 2022; 70(16): 4839 doi: 10.1021/acs.jafc.2c00744
99
Ludovico Abenavoli, Anna Caterina Procopio, Maria Rosaria Paravati, Giosuè Costa, Nataša Milić, Stefano Alcaro, Francesco Luzza. Mediterranean Diet: The Beneficial Effects of Lycopene in Non-Alcoholic Fatty Liver Disease. Journal of Clinical Medicine 2022; 11(12): 3477 doi: 10.3390/jcm11123477
100
Farah D.R. Al-Baiaty, Aziana Ismail, Zarina Abdul Latiff, Khairul Najmi Muhammad Nawawi, Raja Affendi Raja Ali, Norfilza Mohd Mokhtar. Possible Hepatoprotective Effect of Tocotrienol-Rich Fraction Vitamin E in Non-alcoholic Fatty Liver Disease in Obese Children and Adolescents. Frontiers in Pediatrics 2021; 9 doi: 10.3389/fped.2021.667247
101
Kexin Tao, Han Peng, Xin Bi, Xiaoya Wang, Yue Tian, Hua Zhang, Yong Sun. Effect of Tetrastigma hemsleyanum leaves and Extract supplementation on liver metabolomics and the gut microbiota in alcohol-induced liver injury. Food Bioscience 2024; 58: 103617 doi: 10.1016/j.fbio.2024.103617
102
Subramaniyam Nithyananthan, Dangudubiyyam Sushmaa, Ibansiewdor Myrthong, Lokanatha Valluru, Shreyoshi Guha, Ishfaq Hassan Mir, Jajnasenee Behera, Chinnasamy Thirunavukkarasu. Curcuma longaandTrigonella foenum graecum‐enriched nutrient mixture from germinatedMacrotyloma uniflorumandVigna radiateameliorate nonalcoholic fatty liver diseases in rats. Journal of Food Biochemistry 2020; 44(4) doi: 10.1111/jfbc.13159
103
P. Ye, L. Gao, Z. Xia, L. Peng, X. Shi, J. Ma, Y. Dong, D. Dai, Q. Yang, X. Chen, X. Fan, N. Wan, J. Zhang, B. Li, L. Zhou, G. Wu, L. Yang, X. Li, Y. Yan, Y. He. Association between non-alcoholic fatty liver disease and metabolic abnormalities in children with different weight statuses. Public Health 2024; 235: 160 doi: 10.1016/j.puhe.2024.06.004
104
Madalina Andreea Robea, Ioana-Miruna Balmus, Irina Girleanu, Laura Huiban, Cristina Muzica, Alin Ciobica, Carol Stanciu, Carmen Diana Cimpoesu, Anca Trifan. Coagulation Dysfunctions in Non-Alcoholic Fatty Liver Disease—Oxidative Stress and Inflammation Relevance. Medicina 2023; 59(9): 1614 doi: 10.3390/medicina59091614
105
Arash Karimi, Mahdi Vajdi, Sarvin Sanaie, Shiva Akhlaghi, Aida Negari, Farzaneh Dashti, Pouria Sefidmooye Azar, Rafik Balti. A Comprehensive Insight into the Effect of Berberine on Nonalcoholic Fatty Liver Disease (NAFLD): A Systematic Review. Journal of Food Biochemistry 2023; 2023: 1 doi: 10.1155/2023/7277060
106
Raquel Cano, José Pérez, Lissé Dávila, Ángel Ortega, Yosselin Gómez, Nereida Valero-Cedeño, Heliana Parra, Alexander Manzano, Teresa Véliz Castro, María Albornoz, Gabriel Cano, Joselyn Rojas-Quintero, Maricarmen Chacín, Valmore Bermúdez. Role of Endocrine-Disrupting Chemicals in the Pathogenesis of Non-Alcoholic Fatty Liver Disease: A Comprehensive Review. International Journal of Molecular Sciences 2021; 22(9): 4807 doi: 10.3390/ijms22094807
107
Zeyu Li, Hong Wang, Kanglin Wu, Lianfeng Zhang. Omarigliptin protects against nonalcoholic fatty liver disease by ameliorating oxidative stress and inflammation. Journal of Biochemical and Molecular Toxicology 2021; 35(12) doi: 10.1002/jbt.22914
108
Jernej Brecelj, Rok Orel. Non-Alcoholic Fatty Liver Disease in Children. Medicina 2021; 57(7): 719 doi: 10.3390/medicina57070719
109
I-Chuan Yen, Jung-Chun Lin, Yu Chen, Qian-Wen Tu, Shih-Yu Lee. Antrodia Cinnamomea Attenuates Non-Alcoholic Steatohepatitis by Suppressing NLRP3 Inflammasome Activation In Vitro and In Vivo. The American Journal of Chinese Medicine 2020; 48(08): 1859 doi: 10.1142/S0192415X20500937
110
Otilia Frasinariu, Roxana Serban, Laura Mihaela Trandafir, Ingrith Miron, Magdalena Starcea, Ioana Vasiliu, Anna Alisi, Oana Raluca Temneanu. The Role of Phytosterols in Nonalcoholic Fatty Liver Disease. Nutrients 2022; 14(11): 2187 doi: 10.3390/nu14112187
111
Ying-Le Tang, Lin Zhu, Yan Tao, Wen Lu, Hong Cheng. Role of targeting TLR4 signaling axis in liver-related diseases. Pathology - Research and Practice 2023; 244: 154410 doi: 10.1016/j.prp.2023.154410
112
Rong Xie, Shaodong Chen, Fang Li, Liu Yang, Bangliang Yu. Pirfenidone attenuates nonalcoholic fatty liver disease through activation of the nuclear factor erythroid 2‐related factor 2 (Nrf2) signaling pathway. Journal of Biochemical and Molecular Toxicology 2023; 37(2) doi: 10.1002/jbt.23251
113
Hao Wang, Chunlan Shan, Gangjun Guo, Delu Ning, Fujun Miao. Therapeutic potential of palmitoleic acid in non-alcoholic fatty liver disease: Targeting ferroptosis and lipid metabolism disorders. International Immunopharmacology 2024; 142: 113025 doi: 10.1016/j.intimp.2024.113025
114
Wenliang He, Erin A Posey, Chandler C Steele, Jeffrey W Savell, Fuller W Bazer, Guoyao Wu. Dietary glycine supplementation enhances glutathione availability in tissues of pigs with intrauterine growth restriction. Journal of Animal Science 2024; 102 doi: 10.1093/jas/skae025
115
Yu-Qi Li, Lei Xin, Yu-Chi Zhao, Shang-Qi Li, Ya-Nuo Li. Role of vascular endothelial growth factor B in nonalcoholic fatty liver disease and its potential value. World Journal of Hepatology 2023; 15(6): 786-796 doi: 10.4254/wjh.v15.i6.786
116
Yan Yang, Wenting Zhang, Xiaohui Wu, Jing Wu, Chengjun Sun, Feihong Luo, Zhou Pei, Fernand Pierre Gendron. Systemic Overexpression of GDF5 in Adipocytes but Not Hepatocytes Alleviates High-Fat Diet-Induced Nonalcoholic Fatty Liver in Mice. Canadian Journal of Gastroenterology and Hepatology 2021; 2021: 1 doi: 10.1155/2021/8894685
117
Amira M. Badr, Iman O. Sherif, Yasmen F. Mahran, Hala A. Attia. The Renin Angiotensin System in Cancer, Lung, Liver and Infectious Diseases. Advances in Biochemistry in Health and Disease 2023; 25: 179 doi: 10.1007/978-3-031-23621-1_10
118
Rachmad Anres Dongoran, Fang-Cen Tu, Chin-Hung Liu. Current insights into the interplay between gut microbiota-derived metabolites and metabolic-associated fatty liver disease. Tzu Chi Medical Journal 2023; 35(4): 290 doi: 10.4103/tcmj.tcmj_122_23
119
Weiju Xue, Jiarong Wang, Wei Jiang, Congjian Shi, Xiaohong Wang, Yan Huang, Chengmu Hu. Caveolin-1 alleviates lipid accumulation in NAFLD associated with promoting autophagy by inhibiting the Akt/mTOR pathway. European Journal of Pharmacology 2020; 871: 172910 doi: 10.1016/j.ejphar.2020.172910
120
Pentraxin 3 and the TyG Index as Two Novel Markers to Diagnose NAFLD in Children. Disease Markers 2021; 2021: 1 doi: 10.1155/2021/8833287
121
Danting Mao, Jianwei Guo, Kunli Yang, Fan Yang, Jiaojiao Peng, Xu Jia, Ziren Luo, Lu Liu, Enjie Yang, Rui Tang, Haitao Lan, Qian Zheng. Mechanism of epigallocatechin gallate in treating non-alcoholic fatty liver disease: Insights from network pharmacology and experimental validation. Biochemical and Biophysical Research Communications 2024; 734: 150424 doi: 10.1016/j.bbrc.2024.150424
122
Cristiane Cosmo Silva-Luis, Mariana Souza Lopes, Sávio Marcelino Gomes, Palloma Karlla Cantalice Matias, Fernando Paiva Brandini, Paulo César Trindade Costa, Rúbia Cartaxo Squizato de Moraes, Vinícius José Baccin Martins, José Luiz de Brito Alves. Ultra-Processed Food Consumption and Cardiometabolic Risk Factors in Children Living in Northeastern Brazil. Nutrients 2024; 16(22): 3944 doi: 10.3390/nu16223944
123
Haoran Chen, Xiaofen Qi, Kaifang Guan, Yuxiang Gu, Rongchun Wang, Qiming Li, Ying Ma. Peptides released from bovine α-lactalbumin by simulated digestion alleviated free fatty acids-induced lipid accumulation in HepG2 cells. Journal of Functional Foods 2021; 85: 104618 doi: 10.1016/j.jff.2021.104618
124
Lin Ji, Huan Deng, Huimin Xue, Jiting Wang, Kexin Hong, Yunxiao Gao, Xiping Kang, Guanghe Fan, Weidong Huang, Jicheng Zhan, Yilin You. Research progress regarding the effect and mechanism of dietary phenolic acids for improving nonalcoholic fatty liver disease via gut microbiota. Comprehensive Reviews in Food Science and Food Safety 2023; 22(2): 1128 doi: 10.1111/1541-4337.13106
125
Yunfei Xing, Jiangao Fan, Hai-Jun Wang, Hui Wang. Comparison of MAFLD and NAFLD Characteristics in Children. Children 2023; 10(3): 560 doi: 10.3390/children10030560
126
Kai Ushio, Yukio Mikami, Hiromune Obayashi, Hironori Fujishita, Kouki Fukuhara, Tetsuhiko Sakamitsu, Kazuhiko Hirata, Yasunari Ikuta, Hiroaki Kimura, Nobuo Adachi. Decreased Muscle-to-Fat Mass Ratio Is Associated with Low Muscular Fitness and High Alanine Aminotransferase in Children and Adolescent Boys in Organized Sports Clubs. Journal of Clinical Medicine 2021; 10(11): 2272 doi: 10.3390/jcm10112272
127
Gulsah Kaya Aksoy, Reha Artan, Cihat Aksoy, Sebahat Özdem, Atike Atalay, Aygen Yılmaz. Role of Soluble Adiponectin Receptor 2 in Non-Alcoholic Fatty Liver Disease in Children. Pediatric Gastroenterology, Hepatology & Nutrition 2019; 22(5): 470 doi: 10.5223/pghn.2019.22.5.470
128
Eric Kalo, Scott Read, Golo Ahlenstiel. Targeting Gut–Liver Axis for Treatment of Liver Fibrosis and Portal Hypertension. Livers 2021; 1(3): 147 doi: 10.3390/livers1030014
129
Bohyun Park, Byungmi Kim, Chung Ho Kim, Hyun Jin Oh, Bomi Park. Association between endocrine-disrupting chemical mixtures and non-alcoholic fatty liver disease with metabolic syndrome as a mediator among adults: A population-based study in Korea. Ecotoxicology and Environmental Safety 2024; 276: 116310 doi: 10.1016/j.ecoenv.2024.116310
130
Ryutaro Kuraji, Satoshi Sekino, Yvonne Kapila, Yukihiro Numabe. Periodontal disease–related nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: An emerging concept of oral‐liver axis. Periodontology 2000 2021; 87(1): 204 doi: 10.1111/prd.12387
131
Ningning Chen, Qiuli Shan, Yu Qi, Wei Liu, Xiaojun Tan, Jinsong Gu. Transcriptome analysis in normal human liver cells exposed to 2, 3, 3′, 4, 4′, 5 - Hexachlorobiphenyl (PCB 156). Chemosphere 2020; 239: 124747 doi: 10.1016/j.chemosphere.2019.124747
132
Yi Chen, Xueyang Chen, Qiang Chen, Chaohui Yu. Non-Alcoholic Fatty Liver Disease and Hypokalemia in Primary Aldosteronism Among Chinese Population. Frontiers in Endocrinology 2021; 12 doi: 10.3389/fendo.2021.565714
133
Siti Aishah Sulaiman, Vicneswarry Dorairaj, Muhammad Nafiz Haidi Adrus. Genetic Polymorphisms and Diversity in Nonalcoholic Fatty Liver Disease (NAFLD): A Mini Review. Biomedicines 2022; 11(1): 106 doi: 10.3390/biomedicines11010106
134
Tianyu Jiang, Yao Xiao, Jinfeng Zhou, Zupeng Luo, Lin Yu, Qichao Liao, Siqi Liu, Xinyi Qi, Hao Zhang, Menglong Hou, WeiWei Miao, Batbold Batsaikhan, Turtushikh Damba, Yunxiao Liang, Yixing Li, Lei Zhou. Arbutin alleviates fatty liver by inhibiting ferroptosis via FTO/SLC7A11 pathway. Redox Biology 2023; 68: 102963 doi: 10.1016/j.redox.2023.102963
135
Ebrahim Abbasi Oshaghi. Role of Toll-like Receptor 4 in the Development of Non-alcoholic Fatty Liver Disease. Avicenna Journal of Medical Biochemistry 2018; 6(2): 24 doi: 10.15171/ajmb.2018.06
136
Costanza Renata Neri, Serena Scapaticci, Francesco Chiarelli, Cosimo Giannini. Liver Steatosis: A Marker of Metabolic Risk in Children. International Journal of Molecular Sciences 2022; 23(9): 4822 doi: 10.3390/ijms23094822
137
Haiyan Liu, Jie Xu, Hui Li, Lina Zhang, Pingzhen Xu. Network pharmacology‐based investigation to explore the effect and mechanism of Erchen decoction against the nonalcoholic fatty liver disease. The Anatomical Record 2021; 304(11): 2605 doi: 10.1002/ar.24770
138
Shuai Wu, Ning Guo, Hanlin Xu, Yu Li, Tianyin Sun, Xiangfu Jiang, Dongdong Fu, Tingyu You, Shaoxi Diao, Yan Huang, Chengmu Hu. Caveolin-1 ameliorates hepatic injury in non-alcoholic fatty liver disease by inhibiting ferroptosis via the NOX4/ROS/GPX4 pathway. Biochemical Pharmacology 2024; 230: 116594 doi: 10.1016/j.bcp.2024.116594
139
Yuanshe Huang, Xiaodong Wang, Lai Zhang, Ke Zheng, Jie Xiong, Jing Li, Chunlei Cong, Zhaomiao Gong, Jingxin Mao, Lei Chen. Effect of Probiotics Therapy on Nonalcoholic Fatty Liver Disease. Computational and Mathematical Methods in Medicine 2022; 2022: 1 doi: 10.1155/2022/7888076
140
S. V. Orlova, A. N. Vodolazkaya, O. I. Tarasova, E. A. Nikitina, E. V. Prokopenko, N. V. Balashova, I. S. Minosyan, V. V. Urazov. Phytonutrients in complex diet therapy for alcoholic liver disease and non-alcoholic fatty liver disease. Medical alphabet 2024; (16): 13 doi: 10.33667/2078-5631-2024-16-13-18
141
Ying-Xin Xian, Jian-Ping Weng, Fen Xu. MAFLD vs. NAFLD: shared features and potential changes in epidemiology, pathophysiology, diagnosis, and pharmacotherapy. Chinese Medical Journal 2021; 134(1): 8 doi: 10.1097/CM9.0000000000001263
142
Ziming Mao, Xiaowen Ma, Yu Jing, Minyan Shen, Xirui Ma, Jing Zhu, Huifang Liu, Guangya Zhang, Fengling Chen. Ufmylation on UFBP1 alleviates non-alcoholic fatty liver disease by modulating hepatic endoplasmic reticulum stress. Cell Death & Disease 2023; 14(9) doi: 10.1038/s41419-023-06095-2
143
Meiqi Fan, Young-Jin Choi, Yujiao Tang, Sung Mun Bae, Hyun Pil Yang, Eun-Kyung Kim. Efficacy and Mechanism of Polymerized Anthocyanin from Grape-Skin Extract on High-Fat-Diet-Induced Nonalcoholic Fatty Liver Disease. Nutrients 2019; 11(11): 2586 doi: 10.3390/nu11112586
144
Jiang Du, Yu Ji, Liang Qiao, Yanli Liu, Juntang Lin. Cellular endo‐lysosomal dysfunction in the pathogenesis of non‐alcoholic fatty liver disease. Liver International 2020; 40(2): 271 doi: 10.1111/liv.14311
145
Ludovico Abenavoli, Maria Luisa Gambardella, Giuseppe Guido Maria Scarlata, Ilaria Lenci, Leonardo Baiocchi, Francesco Luzza. The Many Faces of Metabolic Dysfunction-Associated Fatty Liver Disease Treatment: From the Mediterranean Diet to Fecal Microbiota Transplantation. Medicina 2024; 60(4): 563 doi: 10.3390/medicina60040563
146
Valeria Calcaterra, Vittoria Magenes, Matteo Vandoni, Clarissa Berardo, Luca Marin, Alice Bianchi, Erika Cordaro, Giustino Silvestro, Dario Silvestri, Vittoria Carnevale Pellino, Cristina Cereda, Gianvincenzo Zuccotti. Benefits of Physical Exercise as Approach to Prevention and Reversion of Non-Alcoholic Fatty Liver Disease in Children and Adolescents with Obesity. Children 2022; 9(8): 1174 doi: 10.3390/children9081174
147
Wei Song, Tianyi Wang, Xiaole Cui, Lingling Li, Bing Chen, Yanjie Li, Tianli Yue. Lactobacillus coryniformis subsp. torquensT3 alleviates non‐alcoholic fatty liver disease via reconstruction of the gut microbiota and redox system. Journal of the Science of Food and Agriculture 2023; 103(14): 6814 doi: 10.1002/jsfa.12774
148
Nan Zhou, Susu Du, Yanyan Dai, Fan Yang, Xiaonan Li. ω3PUFAs improve hepatic steatosis in postnatal overfed rats and HepG2 cells by inhibiting acetyl‐CoA carboxylase. Food Science & Nutrition 2021; 9(9): 5153 doi: 10.1002/fsn3.2482
149
Hwa‐Li Tan, Shamsul Mohd Zain, Hooi‐Sian Eng, Zahurin Mohamed, Sanjiv Mahadeva, Wah‐Kheong Chan, Peng‐Choong Lau, Roma Choudhury Basu, Rosmawati Mohamed. Allele HLA‐DQB1*06 reduces fibrosis score in patients with non‐alcoholic fatty liver disease. Hepatology Research 2020; 50(8): 947 doi: 10.1111/hepr.13525
150
Guillermo Santos-Sánchez, Ivan Cruz-Chamorro, Ana Isabel Álvarez-Ríos, José María Fernández-Santos, María Victoria Vázquez-Román, Beatriz Rodríguez-Ortiz, Nuria Álvarez-Sánchez, Ana Isabel Álvarez-López, María del Carmen Millán-Linares, Francisco Millán, Justo Pedroche, María Soledad Fernández-Pachón, Patricia Judith Lardone, Juan Miguel Guerrero, Ignacio Bejarano, Antonio Carrillo-Vico. Lupinus angustifolius Protein Hydrolysates Reduce Abdominal Adiposity and Ameliorate Metabolic Associated Fatty Liver Disease (MAFLD) in Western Diet Fed-ApoE−/− Mice. Antioxidants 2021; 10(8): 1222 doi: 10.3390/antiox10081222
151
Ping Li, Cunxia Fan, Yingying Cai, Shu Fang, Yanmei Zeng, Yudan Zhang, Xiaochun Lin, Hongbin Zhang, Yaoming Xue, Meiping Guan. Transplantation of brown adipose tissue up-regulates miR-99a to ameliorate liver metabolic disorders in diabetic mice by targeting NOX4. Adipocyte 2020; 9(1): 57 doi: 10.1080/21623945.2020.1721970
152
Guan Lin, Zhang Xinhe, Tian Haoyu, Jin Xing, Li Dan, Wang Ningning, Sun Jing, Wang Xue, Zeng Zilu, Li Yiling. Epidemiology and lifestyle survey of non-alcoholic fatty liver disease in school-age children and adolescents in Shenyang, Liaoning. BMC Pediatrics 2022; 22(1) doi: 10.1186/s12887-022-03351-w
153
Liyuan Hao, Shenghao Li, Guo Chen, Xiaoyu Hu. Regulation of UCP2 in nonalcoholic fatty liver disease: From mechanisms to natural product. Chemical Biology & Drug Design 2024; 103(2) doi: 10.1111/cbdd.14461
154
Yuqing Cheng, Shuangzhe Lin, Tianyi Ren, Jianbin Zhang, Yingying Shi, Yingwei Chen, Yuanwen Chen. New murine model of alcoholic hepatitis in obesity-induced metabolic-associated fatty liver disease. Experimental Animals 2023; 72(3): 389 doi: 10.1538/expanim.22-0160
155
Bin Liu, Huan Zheng, Guanghui Liu, Zhiling Li. Adiponectin is Inversely Associated with Insulin Resistance in Adolescents with Nonalcoholic Fatty Liver Disease. Endocrine, Metabolic & Immune Disorders - Drug Targets 2022; 22(6): 631 doi: 10.2174/1871530321666210927153831
156
Lihua Zhao, Qiuyu Jiang, Jiaqi Lei, Jian Cui, Xianjie Pan, Yuan Yue, Bingkun Zhang. Bile acid disorders and intestinal barrier dysfunction are involved in the development of fatty liver in laying hens. Poultry Science 2024; 103(12): 104422 doi: 10.1016/j.psj.2024.104422
157
Ashraf K. Awaad, Maher A. Kamel, Magdy M. Mohamed, Madiha H. Helmy, Magda I. Youssef, Eiman I. Zaki, Marwa M. Essawy, Marwa G. A. Hegazy. The role of hepatic transcription factor cAMP response element-binding protein (CREB) during the development of experimental nonalcoholic fatty liver: a biochemical and histomorphometric study. Egyptian Liver Journal 2020; 10(1) doi: 10.1186/s43066-020-00046-8
158
Grzegorz Boryczka, Ewa Kosiorowska, Jakub Świętek, Kaja Głowacka, Marek Waluga. Gut microbiome in non-alcoholic fatty liver disease. Polish Journal of Public Health 2022; 132(1): 11 doi: 10.2478/pjph-2022-0002
159
Erika Choi, Ana Ramirez Tovar, Zhulin He, Dellys M. Soler Soler Rodriguez, Miriam B. Vos, Shruthi Arora, Doris Fadoju. Glucagon-like Peptide-1 Receptor Agonists—A Potential New Medication for Pediatric Metabolic-Dysfunction-Associated Steatotic Liver Disease (MASLD). Children 2024; 11(3): 275 doi: 10.3390/children11030275
160
Resthie R. Putri, Thomas Casswall, Emilia Hagman. Prevalence of increased transaminases and its association with sex, age, and metabolic parameters in children and adolescents with obesity – a nationwide cross-sectional cohort study. BMC Pediatrics 2021; 21(1) doi: 10.1186/s12887-021-02747-4
161
Man Wang, Lei Li, Yannan Xu, Juan Du, Changquan Ling. Roles of hepatic stellate cells in NAFLD: From the perspective of inflammation and fibrosis. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.958428
162
Yajie Chen, Yang Wang, Ziqiang Cui, Wenpeng Liu, Baowang Liu, Qiang Zeng, Xin Zhao, Jian Dou, Jinglin Cao. Endocrine disrupting chemicals: A promoter of non-alcoholic fatty liver disease. Frontiers in Public Health 2023; 11 doi: 10.3389/fpubh.2023.1154837
163
Lihua Xiao, Hua Xiong, Zeyuan Deng, Xin Peng, Kejun Cheng, Hua Zhang, Li Jiang, Yong Sun. Tetrastigma hemsleyanumleaf extracts ameliorate NAFLD in mice with low-grade colitisviathe gut–liver axis. Food & Function 2023; 14(1): 500 doi: 10.1039/D2FO03028D
164
Serena Scapaticci, Ebe D’Adamo, Angelika Mohn, Francesco Chiarelli, Cosimo Giannini. Non-Alcoholic Fatty Liver Disease in Obese Youth With Insulin Resistance and Type 2 Diabetes. Frontiers in Endocrinology 2021; 12 doi: 10.3389/fendo.2021.639548
165
Yangyue Ni, Mengwen Huang, Shiyang Chen, Shihui Wang, Jianfeng Chen. Integrins and NAFLD-associated liver diseases: clinical associations, pathophysiological mechanisms and pharmacological implications. Acta Biochimica et Biophysica Sinica 2024; 56(11): 1573 doi: 10.3724/abbs.2024149
166
Nuria Barbarroja, Miriam Ruiz-Ponce, Laura Cuesta-López, Carlos Pérez-Sánchez, Chary López-Pedrera, Iván Arias-de la Rosa, Eduardo Collantes-Estévez. Nonalcoholic fatty liver disease in inflammatory arthritis: Relationship with cardiovascular risk. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.997270
167
Jing Qi, Jong-Won Kim, Zixiong Zhou, Chae-Woong Lim, Bumseok Kim. Ferroptosis Affects the Progression of Nonalcoholic Steatohepatitis via the Modulation of Lipid Peroxidation–Mediated Cell Death in Mice. The American Journal of Pathology 2020; 190(1): 68 doi: 10.1016/j.ajpath.2019.09.011
168
Marcello Dallio, Mario Romeo, Antonietta Gerarda Gravina, Mario Masarone, Tiziana Larussa, Ludovico Abenavoli, Marcello Persico, Carmelina Loguercio, Alessandro Federico. Nutrigenomics and Nutrigenetics in Metabolic- (Dysfunction) Associated Fatty Liver Disease: Novel Insights and Future Perspectives. Nutrients 2021; 13(5): 1679 doi: 10.3390/nu13051679
169
Arnab Banerjee, Sandip Mukherjee, Bithin Kumar Maji. Worldwide flavor enhancer monosodium glutamate combined with high lipid diet provokes metabolic alterations and systemic anomalies: An overview. Toxicology Reports 2021; 8: 938 doi: 10.1016/j.toxrep.2021.04.009
170
Mojtaba Rashidi, Reza Afarin, Maryam Kouchak, Benyamin Kabizadeh, Masoumeh Shamsi, Mahdi Hatami. Resveratrol and Saroglitazar: A Promising Combination for Targeting TGF-β/Smad3 Signaling and Attenuating Inflammatory Response in Nonalcoholic Steatohepatitis in Rats. Hepatitis Monthly 2023; 23(1) doi: 10.5812/hepatmon-138237
171
Haiyan Zhou, Maeda Toshiyoshi,, Wenli Zhao, Ye Zhao, Yan Zhao. Statins on nonalcoholic fatty liver disease: A systematic review and meta-analysis of 14 RCTs. Medicine 2023; 102(26): e33981 doi: 10.1097/MD.0000000000033981
172
Carolyn Vespoli, Anoop Mohamed Iqbal, Mohammad Nasser Kabbany, Kadakkal Radhakrishnan. Metabolic-Associated Fatty Liver Disease in Childhood and Adolescence. Endocrinology and Metabolism Clinics of North America 2023; 52(3): 417 doi: 10.1016/j.ecl.2023.02.001
173
Yun Ji, Yuan Gao, Hong Chen, Yue Yin, Weizhen Zhang. Indole-3-Acetic Acid Alleviates Nonalcoholic Fatty Liver Disease in Mice via Attenuation of Hepatic Lipogenesis, and Oxidative and Inflammatory Stress. Nutrients 2019; 11(9): 2062 doi: 10.3390/nu11092062
174
Seyedeh Alia Moosavian, Thozhukat Sathyapalan, Tannaz Jamialahmadi, Amirhossein Sahebkar, Giuseppe Ciccarella. The Emerging Role of Nanomedicine in the Management of Nonalcoholic Fatty Liver Disease: A State-of-the-Art Review. Bioinorganic Chemistry and Applications 2021; 2021: 1 doi: 10.1155/2021/4041415
175
Jianbin Zhang, Daixi Jiang, Shuangzhe Lin, Yuqing Cheng, Jiaxing Pan, Wenjin Ding, Yuanwen Chen, Jiangao Fan. Prolyl endopeptidase disruption reduces hepatic inflammation and oxidative stress in methionine-choline-deficient diet-induced steatohepatitis. Life Sciences 2021; 270: 119131 doi: 10.1016/j.lfs.2021.119131
176
Rasoul Akbari, Tahereh Behdarvand, Reza Afarin, Hamid Yaghooti, Mohammad Taha Jalali, Narges Mohammadtaghvaei. Saroglitazar improved hepatic steatosis and fibrosis by modulating inflammatory cytokines and adiponectin in an animal model of non-alcoholic steatohepatitis. BMC Pharmacology and Toxicology 2021; 22(1) doi: 10.1186/s40360-021-00524-8
177
Xiaoli Pan, Yanqiao Zhang. Hepatocyte nuclear factor 4α in the pathogenesis of non-alcoholic fatty liver disease. Chinese Medical Journal 2022; 135(10): 1172 doi: 10.1097/CM9.0000000000002092
178
Abdulrahman Ismaiel, Daniel-Corneliu Leucuta, Stefan-Lucian Popa, Dan L. Dumitrascu. Serum Visfatin Levels in Nonalcoholic Fatty Liver Disease and Liver Fibrosis: Systematic Review and Meta-Analysis. Journal of Clinical Medicine 2021; 10(14): 3029 doi: 10.3390/jcm10143029
179
Zhongyi Zhang, Yunliang He, Mei Zhao, Xin He, Zubing Zhou, Yuanyuan Yue, Tao Shen, Juncheng Liu, Gan Zhang, Yong Zhang. Qinlian Hongqu Decoction Modulates FXR/TGR5/GLP-1 Pathway to Improve Insulin Resistance in NAFLD Mice: Bioinformatics and Experimental Study. ACS Omega 2024; 9(45): 45447 doi: 10.1021/acsomega.4c07463
180
Jacob Beiriger, Kashyap Chauhan, Adnan Khan, Taha Shahzad, Natalia Salinas Parra, Peter Zhang, Sarah Chen, Anh Nguyen, Brian Yan, John Bruckbauer, Dina Halegoua-DeMarzio. Advancements in Understanding and Treating NAFLD: A Comprehensive Review of Metabolic-Associated Fatty Liver Disease and Emerging Therapies. Livers 2023; 3(4): 637 doi: 10.3390/livers3040042
181
Qing Tao, Jing Xie, Yongkang Wu, Yong Jin. Long non-coding RNAs as modulators and therapeutic targets in non-alcoholic fatty liver disease (NAFLD). Gastroenterología y Hepatología (English Edition) 2024; 47(5): 506 doi: 10.1016/j.gastre.2024.04.025
182
Devaraj Ezhilarasan. Unraveling the pathophysiologic role of galectin‐3 in chronically injured liver. Journal of Cellular Physiology 2023; 238(4): 673 doi: 10.1002/jcp.30956
183
Feng Gao, Manyu Chen, Jianfeng Yu, Lu Xu, Lisha Yu, Honglin Jiang, Zhiliang Gu. Tetrahydrocurcumin protects against nonalcoholic fatty liver disease by improving lipid metabolism and redox homeostasis. Journal of Functional Foods 2022; 89: 104957 doi: 10.1016/j.jff.2022.104957
184
Ali KIRIK, Cemal Nuri ERCİN, Hasan GÜREL, Ali Fuat ÇİÇEK, Ali Cem YEKDEŞ, Sultan TÜREL, Serkan TAPAN, Teoman DOĞRU. The relationship of serum bilirubin level with histopathological parameters in patients with nonalcoholic fatty liver disease. DAHUDER Medical Journal 2023; 3(3): 91 doi: 10.56016/dahudermj.1326075
185
Dieter Furthner, Christian-Heinz Anderwald, Peter Bergsten, Anders Forslund, Joel Kullberg, Håkan Ahlström, Hannes Manell, Iris Ciba, Harald Mangge, Katharina Maruszczak, Pia Koren, Sebastian Schütz, Susanne Maria Brunner, Anna Maria Schneider, Daniel Weghuber, Katharina Mörwald. Single Point Insulin Sensitivity Estimator in Pediatric Non-Alcoholic Fatty Liver Disease. Frontiers in Endocrinology 2022; 13 doi: 10.3389/fendo.2022.830012
186
Hyunmi Kim, Da Som Lee, Tae Hyeon An, Hyun-Ju Park, Won Kon Kim, Kwang-Hee Bae, Kyoung-Jin Oh. Metabolic Spectrum of Liver Failure in Type 2 Diabetes and Obesity: From NAFLD to NASH to HCC. International Journal of Molecular Sciences 2021; 22(9): 4495 doi: 10.3390/ijms22094495
187
Mi Hye Kim, Jung Bae Seong, Jae-Won Huh, Yong Chul Bae, Hyun-Shik Lee, Dong-Seok Lee. Peroxiredoxin 5 ameliorates obesity-induced non-alcoholic fatty liver disease through the regulation of oxidative stress and AMP-activated protein kinase signaling. Redox Biology 2020; 28: 101315 doi: 10.1016/j.redox.2019.101315
188
Pawel E. Ferdek, Daria Krzysztofik, Kinga B. Stopa, Agnieszka A. Kusiak, Milena Paw, Dawid Wnuk, Monika A. Jakubowska. When healing turns into killing – the pathophysiology of pancreatic and hepatic fibrosis. The Journal of Physiology 2022; 600(11): 2579 doi: 10.1113/JP281135
189
Nayeon Kim, Sunyoon Jung, Eunjung Lee, Eun-Byeol Jo, Seongjun Yoon, Yoonhwa Jeong. Gryllus bimaculatus De Geer hydrolysates alleviate lipid accumulation, inflammation, and endoplasmic reticulum stress in palmitic acid-treated human hepatoma G2 cells. Journal of Ethnopharmacology 2022; 291: 115117 doi: 10.1016/j.jep.2022.115117
190
Madhangi Parameswaran, Hamzah A Hasan, Jafor Sadeque, Sharan Jhaveri, Chaithanya Avanthika, Abimbola E Arisoyin, Maulik B Dhanani, Swaroopa M Rath . Factors That Predict the Progression of Non-alcoholic Fatty Liver Disease (NAFLD). Cureus 2021;  doi: 10.7759/cureus.20776
191
Maria Elena Capra, Brigida Stanyevic, Antonella Giudice, Delia Monopoli, Nicola Mattia Decarolis, Susanna Esposito, Giacomo Biasucci. Long-Chain Polyunsaturated Fatty Acids Effects on Cardiovascular Risk in Childhood: A Narrative Review. Nutrients 2023; 15(7): 1661 doi: 10.3390/nu15071661
192
Yue Li, Mengjia Lv, Meiling Shen, Xi Gu, Li Zhang, Xingyong Liu, Jing Chen, Likun Gong, Zhili Zuo. Identification of 3H-benzo[b] [1,4] diazepine derivatives as PPARα agonists by in silico studies and biochemical evaluation . Journal of Biomolecular Structure and Dynamics 2024; 42(19): 10256 doi: 10.1080/07391102.2023.2256867
193
Yohwan Lim, Seogsong Jeong, Myunghee Hong, Hyun Wook Han. Non-Alcoholic Fatty Liver Disease, Atherosclerosis, and Cardiovascular Disease in Asia. Reviews in Cardiovascular Medicine 2023; 24(6) doi: 10.31083/j.rcm2406173
194
Mirjana Macvanin, Milan Obradovic, Sonja Zafirovic, Julijana Stanimirovic, Esma R. Isenovic. The Role of miRNAs in Metabolic Diseases. Current Medicinal Chemistry 2023; 30(17): 1922 doi: 10.2174/0929867329666220801161536
195
Maria Felicia Faienza, Mariangela Chiarito, Emilio Molina-Molina, Harshitha Shanmugam, Frank Lammert, Marcin Krawczyk, Gabriele D’Amato, Piero Portincasa. Childhood obesity, cardiovascular and liver health: a growing epidemic with age. World Journal of Pediatrics 2020; 16(5): 438 doi: 10.1007/s12519-020-00341-9
196
Richard E. Brown. Genetically modified mice for research on human diseases: A triumph for Biotechnology or a work in progress?. The EuroBiotech Journal 2022; 6(2): 61 doi: 10.2478/ebtj-2022-0008
197
雯 郭. Research Progress of Porphyrin Metabolism in Fatty Liver Disease. Advances in Clinical Medicine 2024; 14(07): 321 doi: 10.12677/acm.2024.1472017
198
Shengying Gu, Shanshan Hu, Shuowen Wang, Chendong Qi, Chenyang Shi, Guorong Fan. Bidirectional association between NAFLD and gallstone disease: a systematic review and meta-analysis of observational studies. Expert Review of Gastroenterology & Hepatology 2023; 17(3): 283 doi: 10.1080/17474124.2023.2175671
199
Jian-Wei Zhang, Hai-Tao Pan. microRNA profiles of serum exosomes derived from children with nonalcoholic fatty liver. Genes & Genomics 2022; 44(7): 879 doi: 10.1007/s13258-021-01150-8
200
Junaura R. Barretto, Ney Boa-Sorte, Caian L. Vinhaes, Hayna Malta-Santos, Jessica Rebouças-Silva, Camila F. Ramos, Monica A. S. Torres-Nascimento, Valeria M. Borges, Bruno B. Andrade. Heightened Plasma Levels of Transforming Growth Factor Beta (TGF-β) and Increased Degree of Systemic Biochemical Perturbation Characterizes Hepatic Steatosis in Overweight Pediatric Patients: A Cross-Sectional Study. Nutrients 2020; 12(6): 1650 doi: 10.3390/nu12061650
201
Qing Tao, Jing Xie, Yongkang Wu, Yong Jin. Long non-coding RNAs as modulators and therapeutic targets in non-alcoholic fatty liver disease (NAFLD). Gastroenterología y Hepatología 2024; 47(5): 506 doi: 10.1016/j.gastrohep.2023.09.014
202
Mengfei Ning, Linfei Song, Xinyu Niu, Yiming Wang, Wenjie Liu, Jiaxiang Hu, Han Cai, Weitao Song, Long Liu, Huifang Li, Daoqing Gong, Jacqueline Smith, Yinhua Huang. Multiscale 3D genome organization underlies duck fatty liver with no adipose inflammation or serious injury. International Journal of Biological Macromolecules 2024; 271: 132452 doi: 10.1016/j.ijbiomac.2024.132452
203
ZhenYu Zhu, Ting Cao, Hui Chen, BiKui Zhang, ChenQuan Lin, HuaLin Cai. Olanzapine-induced nonalcoholic fatty liver disease: The effects of differential food pattern and the involvement of PGRMC1 signaling. Food and Chemical Toxicology 2023; 176: 113757 doi: 10.1016/j.fct.2023.113757
204
Ha-Neul Choi, Jin-Yeong Shin, Jung-In Kim. Ameliorative Effect of Myricetin on Nonalcoholic Fatty Liver Disease in ob/ob Mice. Journal of Medicinal Food 2021; 24(10): 1092 doi: 10.1089/jmf.2021.K.0090
205
Qingyan Ye, Yun Jiang, Di Wu, Jingwen Cai, Zhitian Jiang, Zhen Zhou, Liyan Liu, Qihua Ling, Qian Wang, Gang Zhao. Atractylodin alleviates nonalcoholic fatty liver disease by regulating Nrf2-mediated ferroptosis. Heliyon 2023; 9(7): e18321 doi: 10.1016/j.heliyon.2023.e18321
206
Melisa Kozaczek, Byungwhi Kong, Walter Bottje, Reza Hakkak. Hepatic Proteomics Analysis of Nonalcoholic Fatty Liver Disease Obese Rat Model After Short- and Long-Term Soy Protein Isolate Feeding. Journal of Medicinal Food 2022; 25(3): 293 doi: 10.1089/jmf.2021.0088
207
Ping Li, Jianran Hu, Hongmei Zhao, Jing Feng, Baofeng Chai. Multi-Omics Reveals Inhibitory Effect of Baicalein on Non-Alcoholic Fatty Liver Disease in Mice. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.925349
208
Yupeng Liu, Jingjing Song, Juan Yang, Jilin Zheng, Ling Yang, Jun Gao, Song Tian, Zhen Liu, Xiangbin Meng, Jian‐Cheng Wang, Zhifei Dai, Yi‐Da Tang. Tumor Necrosis Factor α–Induced Protein 8–Like 2 Alleviates Nonalcoholic Fatty Liver Disease Through Suppressing Transforming Growth Factor Beta–Activated Kinase 1 Activation. Hepatology 2021; 74(3): 1300 doi: 10.1002/hep.31832
209
Victoria L. Slaughter, John W. Rumsey, Rachel Boone, Duaa Malik, Yunqing Cai, Narasimhan Narasimhan Sriram, Christopher J. Long, Christopher W. McAleer, Stephen Lambert, Michael L. Shuler, J. J. Hickman. Validation of an adipose-liver human-on-a-chip model of NAFLD for preclinical therapeutic efficacy evaluation. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-92264-2
210
Xing Yan, Linnan Li, Pei Liu, Jie Xu, Zhengtao Wang, Lili Ding, Li Yang. Targeted Metabolomics Profiles Serum Fatty Acids by HFD Induced Non-Alcoholic Fatty Liver in Mice Based on GC-MS. SSRN Electronic Journal 2021;  doi: 10.2139/ssrn.3954272
211
Feng-Zhi Xin, Ze-Hua Zhao, Rui-Nan Zhang, Qin Pan, Zi-Zhen Gong, Chao Sun, Jian-Gao Fan. Folic acid attenuates high-fat diet-induced steatohepatitis <i>via</i> deacetylase SIRT1-dependent restoration of PPARα. World Journal of Gastroenterology 2020; 26(18): 2203-2220 doi: 10.3748/wjg.v26.i18.2203
212
Zhen Yang, Zhiwei Xiong, Qiuguo Wang, Ning Zhou. A bibliometric analysis of macrophages associated with non-alcoholic fatty liver disease research from 2005 to 2023. Heliyon 2024; 10(2): e24187 doi: 10.1016/j.heliyon.2024.e24187
213
Ilaria Demori, Elena Grasselli. The Role of the Stress Response in Metabolic Dysfunction-Associated Fatty Liver Disease: A Psychoneuroendocrineimmunology-Based Perspective. Nutrients 2023; 15(3): 795 doi: 10.3390/nu15030795
214
Antonella Mosca, Giuseppe Maggiore. Malattia grassa del fegato: tra fattori ambientali e predisposizione genetica. Medico e Bambino 2023; 42(6): 355 doi: 10.53126/MEB42355
215
Hee-Kyoung Son, Bok-Hee Kim, Jisu Lee, Seohyun Park, Chung-Bae Oh, Sunyoon Jung, Jennifer K. Lee, Jung-Heun Ha. Partial Replacement of Dietary Fat with Krill Oil or Coconut Oil Alleviates Dyslipidemia by Partly Modulating Lipid Metabolism in Lipopolysaccharide-Injected Rats on a High-Fat Diet. International Journal of Environmental Research and Public Health 2022; 19(2): 843 doi: 10.3390/ijerph19020843
216
Xinhe Zhang, Lin Guan, Haoyu Tian, Zilu Zeng, Jiayu Chen, Die Huang, Ji Sun, Jiaqi Guo, Huipeng Cui, Yiling Li. Risk Factors and Prevention of Viral Hepatitis-Related Hepatocellular Carcinoma. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.686962
217
Zheng Yang, Daoqing Gong, Xinxiang He, Fei Huang, Yi Sun, Qinming Hu. Association between daidzein intake and metabolic associated fatty liver disease: A cross-sectional study from NHANES 2017–2018. Frontiers in Nutrition 2023; 10 doi: 10.3389/fnut.2023.1113789
218
Hammad Ahmed, Muhammad Ihtisham Umar, Salman Imran, Faraza Javaid, Shahzada Khurram Syed, Romana Riaz, Waseem Hassan. TGF-β1 signaling can worsen NAFLD with liver fibrosis backdrop. Experimental and Molecular Pathology 2022; 124: 104733 doi: 10.1016/j.yexmp.2021.104733
219
Zhuoyu Li, Mengyao Zhao, Xiaoguo Ji, Liqiang Fan, Liming Zhao. Alginate oligosaccharides improve high-fat induced hepatic steatosis via PGC-1α-mediated lipophagy and fatty acid β-oxidation pathway. Journal of Functional Foods 2023; 110: 105825 doi: 10.1016/j.jff.2023.105825
220
Mioara Desdemona Stepan, Ștefănița Bianca Vintilescu, Ioana Streață, Mihaela Andreea Podeanu, Dan Nicolae Florescu. The Role of Vitamin D in Obese Children with Non-Alcoholic Fatty Liver Disease and Associated Metabolic Syndrome. Nutrients 2023; 15(9): 2113 doi: 10.3390/nu15092113
221
Shujuan Guo, Juan Zheng, Guimei Li. Effects of growth hormone on lipid metabolism and sexual development in pubertal obese male rats. Open Life Sciences 2022; 17(1): 1531 doi: 10.1515/biol-2022-0515
222
Hasen A. Al-ghamdi, Fayza F. Al Fayez, Abdulhadi I. Bima, Taghreed M. Khawaji, Ayman Z. Elsamanoudy. Study of Cellular Senescence and Vitamin D Deficiency in Nonalcoholic Fatty Liver Disease and The Potential Protective Effect of Vitamin D Supplementation. Journal of Clinical and Experimental Hepatology 2021; 11(2): 219 doi: 10.1016/j.jceh.2020.07.003
223
Z. Yang, P. Li, Q. Shang, Y. Wang, J. He, S. Ge, R. Jia, X. Fan. CRISPR-mediated BMP9 ablation promotes liver steatosis via the down-regulation of PPARα expression. Science Advances 2020; 6(48) doi: 10.1126/sciadv.abc5022
224
Tao Zhang, Yingli Nie, Jiliang Wang. The emerging significance of mitochondrial targeted strategies in NAFLD treatment. Life Sciences 2023; 329: 121943 doi: 10.1016/j.lfs.2023.121943
225
Dong-fang Fu, Bin Chen. The relationship between the systemic immune inflammation index and the nonalcoholic fatty liver disease in American adolescents. BMC Gastroenterology 2024; 24(1) doi: 10.1186/s12876-024-03324-6
226
Guoliang Yin, Hongyi Liang, Wenxiu Sun, Shizhao Zhang, Yanan Feng, Pengpeng Liang, Suwen Chen, Xiangyi Liu, Wenchao Pan, Fengxia Zhang. Shuangyu Tiaozhi decoction alleviates non-alcoholic fatty liver disease by improving lipid deposition, insulin resistance, and inflammation in vitro and in vivo. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.1016745
227
Matthew C. Sinton, David C. Hay, Amanda J. Drake. Metabolic control of gene transcription in non-alcoholic fatty liver disease: the role of the epigenome. Clinical Epigenetics 2019; 11(1) doi: 10.1186/s13148-019-0702-5
228
Jin Hwa Kim, Young Sang Lyu, Mee Kyoung Kim, Sang Yong Kim, Ki‐Hyun Baek, Ki‐Ho Song, Kyungdo Han, Hyuk‐Sang Kwon. Repeated detection of non‐alcoholic fatty liver disease increases the incidence risk of type 2 diabetes in young adults. Diabetes, Obesity and Metabolism 2024; 26(1): 180 doi: 10.1111/dom.15304
229
翠愿 郭. Type 2 Diabetes Mellitus and Nonalcoholic Fatty Liver Disease: Correlation and Management. Advances in Clinical Medicine 2024; 14(08): 605 doi: 10.12677/acm.2024.1482257
230
Shumin Wei, Xiaoying Yu. Efficacy of resveratrol supplementation on liver enzymes in patients with non-alcoholic fatty liver disease: A systematic review and meta-analysis. Complementary Therapies in Medicine 2021; 57: 102635 doi: 10.1016/j.ctim.2020.102635
231
Waleed Alghamdi, Mahmoud Mosli, Saleh A. Alqahtani. Gut microbiota in MAFLD: therapeutic and diagnostic implications. Therapeutic Advances in Endocrinology and Metabolism 2024; 15 doi: 10.1177/20420188241242937
232
Yin-Zhao Jia, Qiao-Juan Mei, Yong Zhang. MiR-484 participates in non-alcoholic fatty liver injury by targeting SIRT1 to mediate cell apoptosis. World Chinese Journal of Digestology 2021; 29(8): 389 doi: 10.11569/wcjd.v29.i8.389
Abstract() |  Core Tip() |  Full Article(HTML)() | Times Cited  (0) | Total Visits (0) | Open
233
Lide Arenaza, María Medrano, Maddi Oses, Maria Amasene, Ignacio Díez, Beatriz Rodríguez-Vigil, Idoia Labayen. The Effect of a Family-Based Lifestyle Education Program on Dietary Habits, Hepatic Fat and Adiposity Markers in 8–12-Year-Old Children with Overweight/Obesity. Nutrients 2020; 12(5): 1443 doi: 10.3390/nu12051443
234
Shouxing Yang, Jinwei Zhong, Mengsi Ye, Lei Miao, Guangrong Lu, Changlong Xu, Zhanxiong Xue, Xinhe Zhou. Association between the non-HDL-cholesterol to HDL-cholesterol ratio and non-alcoholic fatty liver disease in Chinese children and adolescents: a large single-center cross-sectional study. Lipids in Health and Disease 2020; 19(1) doi: 10.1186/s12944-020-01421-5
235
Juana Carretero-Gómez, Francisco Javier Carrasco-Sánchez, José María Fernández-Rodríguez, Pedro Casado-Escribano, José Pablo Miramontes-González, José Miguel Seguí-Ripoll, Javier Ena, José Carlos Arévalo-Lorido. Effect of semaglutide on fatty liver disease biomarkers in patients with diabetes and obesity. Revista Clínica Española (English Edition) 2023; 223(3): 134 doi: 10.1016/j.rceng.2022.12.001
236
Panli Tan, Li Jin, Xiang Qin, Beihui He. Natural flavonoids: Potential therapeutic strategies for non-alcoholic fatty liver disease. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.1005312
237
Dhadhang Wahyu Kurniawan, Gert Storm, Jai Prakash, Ruchi Bansal. Role of spleen tyrosine kinase in liver diseases. World Journal of Gastroenterology 2020; 26(10): 1005-1019 doi: 10.3748/wjg.v26.i10.1005
238
Tianyang Huang, Yahui Liu, Huiming Li, Ying Zhang, Dezhi Kong, Guozhen Cui. β‐Glucan ameliorates nonalcoholic steatohepatitis induced by methionine and choline‐deficient diet in mice. Journal of Food Biochemistry 2020; 44(10) doi: 10.1111/jfbc.13408
239
Li-Hong He, Dun-Han Yao, Ling-Yun Wang, Lei Zhang, Xue-Li Bai. Gut Microbiome-Mediated Alteration of Immunity, Inflammation, and Metabolism Involved in the Regulation of Non-alcoholic Fatty Liver Disease. Frontiers in Microbiology 2021; 12 doi: 10.3389/fmicb.2021.761836
240
Averie Dickinson, Amreen Dinani, Kara Wegermann. Chemoprevention of hepatocellular carcinoma associated with metabolic dysfunction-associated steatotic liver disease: an updated review. Hepatoma Research 2024;  doi: 10.20517/2394-5079.2024.81
241
Yu-Tsung Chou, Chung-Hao Li, Zih-Jie Sun, Wei-Chen Shen, Yi-Ching Yang, Feng-Hwa Lu, Chih-Jen Chang, Jin-Shang Wu. A Positive Relationship between Betel Nut Chewing and Significant Liver Fibrosis in NAFLD Subjects, but Not in Non-NAFLD Ones. Nutrients 2021; 13(3): 914 doi: 10.3390/nu13030914
242
Marina V. Maevskaya, Yulia V. Kotovskaya, Vladimir T. Ivashkin, Olga N. Tkacheva, Ekaterina A. Troshina, Marina V. Shestakova, Valeriy V. Breder, Natalia I. Geyvandova, Vladimir L. Doshchitsin, Ekaterina N. Dudinskaya, Ekaterina V. Ershova, Khava B. Kodzoeva, Ksenia A. Komshilova, Natalia V. Korochanskaya, Alexander Yu. Mayorov, Ekaterina E. Mishina, Maria Yu. Nadinskaya, Igor G. Nikitin, Nana V. Pogosova, Aida I. Tarzimanova, Minara Sh. Shamkhalova. The National Consensus statement on the management of adult patients with non-alcoholic fatty liver disease and main comorbidities. Terapevticheskii arkhiv 2022; 94(2): 216 doi: 10.26442/00403660.2022.02.201363
243
Jingyuan Xu, Hongyang Tian, Yajun Ji, Lei Dong, Yandong Liu, Yatao Wang, Xuefen Gao, Haitao Shi, Hong Li, Longbao Yang. Urolithin C reveals anti-NAFLD potential via AMPK-ferroptosis axis and modulating gut microbiota. Naunyn-Schmiedeberg's Archives of Pharmacology 2023; 396(10): 2687 doi: 10.1007/s00210-023-02492-8
244
Livhuwani P. Nendouvhada, Nicole R. S. Sibuyi, Adewale O. Fadaka, Samantha Meyer, Abram M. Madiehe, Mervin Meyer, Kwazikwakhe B. Gabuza. Phytonanotherapy for the Treatment of Metabolic Dysfunction-Associated Steatotic Liver Disease. International Journal of Molecular Sciences 2024; 25(11): 5571 doi: 10.3390/ijms25115571
245
Yinhua Ni, Liyang Ni, Fen Zhuge, Zhengwei Fu. The Gut Microbiota and Its Metabolites, Novel Targets for Treating and Preventing Non‐Alcoholic Fatty Liver Disease. Molecular Nutrition & Food Research 2020; 64(17) doi: 10.1002/mnfr.202000375
246
Igor V Maev, Aleksey A Samsonov, Liudmila K Palgova, Chavdar S Pavlov, Elena I Vovk, Elena N Shirokova, Kirill M Starostin. Effectiveness of phosphatidylcholine in alleviating steatosis in patients with non-alcoholic fatty liver disease and cardiometabolic comorbidities (MANPOWER study). BMJ Open Gastroenterology 2020; 7(1): e000341 doi: 10.1136/bmjgast-2019-000341
247
Hai-Xin Chen, Fan Yang, Xin-Qian He, Ting Li, Yong-Zhi Sun, Jian-Ping Song, Xin-An Huang, Wen-Feng Guo. Garcinia Biflavonoid 1 Improves Lipid Metabolism in HepG2 Cells via Regulating PPARα. Molecules 2022; 27(6): 1978 doi: 10.3390/molecules27061978
248
Melisa Kozaczek, Walter Bottje, Diyana Albataineh, Reza Hakkak. Effects of Short- and Long-Term Soy Protein Feeding on Hepatic Cytochrome P450 Expression in Obese Nonalcoholic Fatty Liver Disease Rat Model. Frontiers in Nutrition 2021; 8 doi: 10.3389/fnut.2021.699620
249
Jiali Zhang, Baochen Ma, Zixu Wang, Yaoxing Chen, Chengzhong Li, Yulan Dong. Extracellular vesicle therapy for obesity-induced NAFLD: a comprehensive review of current evidence. Cell Communication and Signaling 2024; 22(1) doi: 10.1186/s12964-023-01292-0
250
Yan Jiang, Narazah Mohd Yusoff, Jiang Du, Emmanuel Jairaj Moses, Jun-Tang Lin. Current perspectives on mesenchymal stem cells as a potential therapeutic strategy for non-alcoholic fatty liver disease. World Journal of Stem Cells 2024; 16(7): 760-772 doi: 10.4252/wjsc.v16.i7.760
251
Hatice Merve Bayram, Fuzail Mohammed Majoo, Arda Ozturkcan. Polyphenols in the prevention and treatment of non-alcoholic fatty liver disease: An update of preclinical and clinical studies. Clinical Nutrition ESPEN 2021; 44: 1 doi: 10.1016/j.clnesp.2021.06.026
252
Noha M. Hany, Sanaa Eissa, Manal Basyouni, Amany H. Hasanin, Yasmin M. Aboul-Ela, Nagwa M. Abo Elmagd, Iman F. Montasser, Mahmoud A. Ali, Paul J. Skipp, Marwa Matboli. Modulation of hepatic stellate cells by Mutaflor® probiotic in non-alcoholic fatty liver disease management. Journal of Translational Medicine 2022; 20(1) doi: 10.1186/s12967-022-03543-z
253
Xu Chen, Xiaoyuan Sun, Tianran Shen, Qian Chen, Shen Chen, Juan Pang, Jiaxin Mi, Yi Tang, Yiran You, Huihui Xu, Wenhua Ling. Lower adropin expression is associated with oxidative stress and severity of nonalcoholic fatty liver disease. Free Radical Biology and Medicine 2020; 160: 191 doi: 10.1016/j.freeradbiomed.2020.08.005
254
Hyun-Jung Park, SunYoung Lee, Minsook Ye, Bong Hee Han, Hyun Soo Shim, Daehyuk Jang, Insop Shim. Anti-Obesity Effect of Chitoglucan in High-Fat-Induced Obesity Mice. International Journal of Environmental Research and Public Health 2022; 20(1): 281 doi: 10.3390/ijerph20010281
255
Michele Walsh, Deborah John, Nicole Peritore, Andrea Morris, Carolyn Bird, Marion Ceraso, Sarah Eichberger, Rachel Novotny, Laura Stephenson, Suzanne Stluka, Roberta Riportella. Health in All Policies: Working Across Sectors in Cooperative Extension to Promote Health for All. Journal of Human Sciences and Extension 2018;  doi: 10.54718/RYTE6013
256
Xinhe Zhang, Haoyu Tian, Yiling Li. The pathophysiological mechanism between hypopituitarism and nonalcoholic fatty liver disease. iLIVER 2022; 1(1): 65 doi: 10.1016/j.iliver.2022.02.004
257
Chance S. Friesen, Chelsea Hosey-Cojocari, Sherwin S. Chan, Iván L. Csanaky, Jonathan B. Wagner, Brooke R. Sweeney, Alec Friesen, Jason D. Fraser, Valentina Shakhnovich. Efficacy of Weight Reduction on Pediatric Nonalcoholic Fatty Liver Disease: Opportunities to Improve Treatment Outcomes Through Pharmacotherapy. Frontiers in Endocrinology 2021; 12 doi: 10.3389/fendo.2021.663351
258
Hager H. Shaaban, Ibrahim Alzaim, Ahmed El-Mallah, Rania G. Aly, Ahmed F. El-Yazbi, Ahmed Wahid. Metformin, pioglitazone, dapagliflozin and their combinations ameliorate manifestations associated with NAFLD in rats via anti-inflammatory, anti-fibrotic, anti-oxidant and anti-apoptotic mechanisms. Life Sciences 2022; 308: 120956 doi: 10.1016/j.lfs.2022.120956
259
Thomas Pixner, Nathalie Stummer, Anna Maria Schneider, Andreas Lukas, Karin Gramlinger, Valérie Julian, David Thivel, Katharina Mörwald, Katharina Maruszczak, Harald Mangge, Julian Gomahr, Daniel Weghuber, Dieter Furthner. The Role of Macronutrients in the Pathogenesis, Prevention and Treatment of Non-Alcoholic Fatty Liver Disease (NAFLD) in the Paediatric Population—A Review. Life 2022; 12(6): 839 doi: 10.3390/life12060839
Write to the Help Desk
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345